The retrospective study’s findings suggest that PR is an effective way to treat noncomplex retinal detachment from the office, not the operating room.
Potentially blinding secondary complication duration can average 17.7 months, the study shows.
Verteporfin dosage significantly affected choroidal blood flow after photodynamic therapy procedure, a report shows.
Preoperative vitreous hemorrhaging was also associated with unsuccessful surgeries.
Visual outcomes appeared more dramatic in the patients who also received scleral buckle.
The study also shows the minimum linear diameter and macular hole index on OCT can be used as markers for prognostic guidance.
Investigators continue to recommend regular fundus examinations.
Researchers offer a new way to help patients maintain correct head positioning after surgery.
Patients who underwent pneumatic retinopexy had less discontinuity of the ellipsoid zone and external limiting membrane.
Optometrists can manage some retinal conditions in their own offices, but others are urgent and will require a specialist referral.
Researchers found similar improvements in both macula-on and macula-off detachments.
In a secondary analysis of data from the EVICT study, conditions such as chorioretinal scarring, retinal detachment, and other posterior pathology were present in 19.2% of EVD survivors.
In a case study series, researchers catalog various presentations of ocular syphilis.
Colleen P. Halfpenny, MD, (Wills Eye) Tania Tai, MD, (New York Eye and Ear) and Vaidehi Dedania, MD, (NYU) all weigh in on how the prospect of rho-kinase inhibitors are primed to change pharmaceutical eye care from the retina to the cornea.
The frequency of urgent or emergent vitreoretinal surgical procedures decreased during the COVID-19 pandemic.
Foveal changes and macular hole presence play a significant role in vision outcomes of macula-off retinal detachment repairs.
Researchers train artificial intelligence to recognize retinal breaks and detachment in tessellated eyes.
Researchers investigate the rate of return to the operating room after vitrectomy.
Researchers investigate the potential damage scleral tattooing can cause to the eye.
Investigators show the impact of intravitreal ranibizumab as an adjunct to ablation therapy for this rare retinal presentation.